Dr Andrew Hill of the Department of Pharmacology at the University of Liverpool (UK) is currently performing a WHO-commissioned review and meta-analysis of randomized controlled trials of ivermectin against covid. In the following 12-minute video, Dr Hill is presenting his preliminary results, which confirm a highly significant 83% reduction in covid mortality (95% CI 65%-92%).
This result is based on in-hospital trials, so it doesn’t even take into account early ambulatory and prophylactic treatment. The WHO now wants to wait for three more trials, due to be published sometime in January, before issuing an official recommendation. At the end of his presentation, Dr Hill speaks of ivermectin as a potentially “transformational treatment”.